Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorH. Lee Moffitt Cancer Center and Research Institute

About this trial

This study will evaluate obesity-mediated mechanisms of pancreatic carcinogenesis in minority populations.

Eligibility criteria

Qualifiers

Adults 18 years of age or older at time of signing informed consent

Patients who self-report as African American, Non-Hispanic White

Patients who present to the gastrointestinal (GI) clinic, surgery, or endoscopy at a participating Florida Pancreas Collaborative (FPC) site or the University of Mississippi Medical Center (UMMC) with a clinical suspicion or diagnosis of a pancreatic tumor.

Disqualifiers

Patient under 18 years of age

Has no suspicion or diagnosis of a pancreatic cancer or tumor

Self-reported race/ethnicity other than African American or Non-Hispanic White.

Trial design

Treatments tested in this trial

  • Blood Sample Collection
  • Tissue Sample Collection
  • Data Collection
  • Medical Image Collection

Treatment groups

125 Participants
are divided into 2 treatment groups

Sponsors and collaborators

H. Lee Moffitt Cancer Center and Research Institute

Lead sponsor

United States Department of Defense

Collaborator